vs

Side-by-side financial comparison of SINOVAC BIOTECH LTD (SVA) and TAKEDA PHARMACEUTICAL CO LTD (TAK). Click either name above to swap in a different company.

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a ...

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SVA
SVA
TAK
TAK
Q2 25
$4.3M
Q1 24
$4.0M
Net Profit
SVA
SVA
TAK
TAK
Q2 25
$144.2K
Q1 24
$317.0K
Gross Margin
SVA
SVA
TAK
TAK
Q2 25
66.5%
Q1 24
69.1%
Operating Margin
SVA
SVA
TAK
TAK
Q2 25
5.0%
Q1 24
12.2%
Net Margin
SVA
SVA
TAK
TAK
Q2 25
3.4%
Q1 24
7.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons